How to Balance Requirements from Payers and Manufacturers

Jon Hamrick, executive vice president, Biotech and Specialty Services at Therigy LLC, discusses how specialty pharmacies can best navigate complex reporting requirements from multiple entities.

Jon Hamrick, executive vice president, Biotech and Specialty Services at Therigy LLC, discusses how specialty pharmacies can best navigate complex reporting requirements from multiple entities.

Related Videos
View All
Related Content

Technology Can Help Ease Provider Burnout, Access to Health Care

February 1st 2023

Pharmacy Focus: Psychedelic Pharmacy - Understanding Natural vs. Synthetic Psychedelics

January 13th 2023

First Humira Biosimilar Launches in the United States

February 1st 2023

Pharmacy Focus: Public Health Matters- Celebrating American Pharmacist Month Part 2 with Autumn Zuckerman

October 13th 2022

New Biomarker May Indicate Success of CAR T-cell Response in Lymphoma Patients

January 26th 2023

Phase 3 Trial Showed Zolbetuximab Significantly Improved Survival In Patients with Metastatic Gastric, Gastroesophageal Cancers

January 26th 2023

Technology Can Help Ease Provider Burnout, Access to Health Care

February 1st 2023

Pharmacy Focus: Psychedelic Pharmacy - Understanding Natural vs. Synthetic Psychedelics

January 13th 2023

First Humira Biosimilar Launches in the United States

February 1st 2023

Pharmacy Focus: Public Health Matters- Celebrating American Pharmacist Month Part 2 with Autumn Zuckerman

October 13th 2022

New Biomarker May Indicate Success of CAR T-cell Response in Lymphoma Patients

January 26th 2023

Phase 3 Trial Showed Zolbetuximab Significantly Improved Survival In Patients with Metastatic Gastric, Gastroesophageal Cancers

January 26th 2023

Technology Can Help Ease Provider Burnout, Access to Health Care

February 1st 2023

Pharmacy Focus: Psychedelic Pharmacy - Understanding Natural vs. Synthetic Psychedelics

January 13th 2023

First Humira Biosimilar Launches in the United States

February 1st 2023

Pharmacy Focus: Public Health Matters- Celebrating American Pharmacist Month Part 2 with Autumn Zuckerman

October 13th 2022

New Biomarker May Indicate Success of CAR T-cell Response in Lymphoma Patients

January 26th 2023

Phase 3 Trial Showed Zolbetuximab Significantly Improved Survival In Patients with Metastatic Gastric, Gastroesophageal Cancers

January 26th 2023
About Us
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.